Upgrade to SI Premium - Free Trial

Form SCHEDULE 13D/A Veradermics, Inc Filed by: Longitude Capital Partners V, LLC

May 5, 2026 9:08 PM





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
All shares are held of record by LVPV (as defined in Item 2(a) below). LCPV (as defined in Item 2(a) below) is the general partner of LVPV and may be deemed to have voting and dispositive power with respect to these securities. Patrick G. Enright, a member of the Issuer's board of directors, and Juliet Tammenoms Bakker are the managing members of LCPV and may each be deemed to share voting and dispositive power with respect to these securities. Based on 41,184,080 shares of Common Stock outstanding, consisting of (i) 37,340,290 shares of Common Stock outstanding as of March 25, 2026, as reported by the Issuer (as defined in Item 1(a) below) in its Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the Commission) on March 30, 2026 (the Form 10-K), plus (ii) 3,843,790 shares of Common Stock sold by the Issuer pursuant to its Registration Statements on Form S-1 (File Nos. 333-295356 and 333-295420), as disclosed in the Issuer's Current Report on Form 8-K, filed with the Commission on May 1, 2026 (the Form 8-K).


SCHEDULE 13D




Comment for Type of Reporting Person:
All shares are held of record by LVPV. LCPV is the general partner of LVPV and may be deemed to have voting and dispositive power with respect to these securities. Patrick G. Enright, a member of the Issuer's board of directors, and Juliet Tammenoms Bakker are the managing members of LCPV and may each be deemed to share voting and dispositive power with respect to these securities. Based on 41,184,080 shares of Common Stock outstanding, consisting of (i) 37,340,290 shares of Common Stock outstanding as of March 25, 2026, as reported by the Issuer in the Form 10-K, plus (ii) 3,843,790 shares of Common Stock sold by the Issuer on May 1, 2026, as disclosed in the Form 8-K.


SCHEDULE 13D




Comment for Type of Reporting Person:
All shares are held of record by L103 (as defined in Item 2(a) below). L103P (as defined in Item 2(a) below) is the general partner of L103 and may be deemed to have voting and dispositive power with respect to these securities. Patrick G. Enright, a member of the Issuer's board of directors, and Juliet Tammenoms Bakker are the managing members of L103P and may each be deemed to share voting and dispositive power with respect to these securities. Based on 41,184,080 shares of Common Stock outstanding, consisting of (i) 37,340,290 shares of Common Stock outstanding as of March 25, 2026, as reported by the Issuer in the Form 10-K, plus (ii) 3,843,790 shares of Common Stock sold by the Issuer on May 1, 2026, as disclosed in the Form 8-K.


SCHEDULE 13D




Comment for Type of Reporting Person:
All shares are held of record by L103. L103P is the general partner of L103 and may be deemed to have voting and dispositive power with respect to these securities. Patrick G. Enright, a member of the Issuer's board of directors, and Juliet Tammenoms Bakker are the managing members of L103P and may each be deemed to share voting and dispositive power with respect to these securities. Based on 41,184,080 shares of Common Stock outstanding, consisting of (i) 37,340,290 shares of Common Stock outstanding as of March 25, 2026, as reported by the Issuer in the Form 10-K, plus (ii) 3,843,790 shares of Common Stock sold by the Issuer on May 1, 2026, as disclosed in the Form 8-K.


SCHEDULE 13D




Comment for Type of Reporting Person:
Consists of (i) 2,600,399 shares of Common Stock held of record by LVPV, and (ii) 2,053,474 shares of Common Stock held of record by L103. LCPV is the general partner of LVPV and may be deemed to have voting and dispositive power with respect to the shares held of record by LVPV. L103P is the general partner of L103 and may be deemed to have voting and dispositive power with respect to the shares held by L103. Patrick G. Enright, a member of the Issuer's board of directors, and Juliet Tammenoms Bakker are the managing members of each of LCPV and L103P and may each be deemed to share voting and dispositive power with respect to the shares held by LVPV and L103. Based on 41,184,080 shares of Common Stock outstanding, consisting of (i) 37,340,290 shares of Common Stock outstanding as of March 25, 2026, as reported by the Issuer in the Form 10-K, plus (ii) 3,843,790 shares of Common Stock sold by the Issuer on May 1, 2026, as disclosed in the Form 8-K.


SCHEDULE 13D




Comment for Type of Reporting Person:
Consists of (i) 2,600,399 shares of Common Stock held of record by LVPV, and (ii) 2,053,474 shares of Common Stock held of record by L103. LCPV is the general partner of LVPV and may be deemed to have voting and dispositive power with respect to the shares held of record by LVPV. L103P is the general partner of L103 and may be deemed to have voting and dispositive power with respect to the shares held by L103. Patrick G. Enright, a member of the Issuer's board of directors, and Juliet Tammenoms Bakker are the managing members of each of LCPV and L103P and may each be deemed to share voting and dispositive power with respect to the shares held by LVPV and L103. Based on 41,184,080 shares of Common Stock outstanding, consisting of (i) 37,340,290 shares of Common Stock outstanding as of March 25, 2026, as reported by the Issuer in the Form 10-K, plus (ii) 3,843,790 shares of Common Stock sold by the Issuer on May 1, 2026, as disclosed in the Form 8-K.


SCHEDULE 13D


Longitude Capital Partners V, LLC
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, Authorized Signatory
Date:05/05/2026
Longitude Venture Partners V, L.P.
Signature:By Longitude Capital Partners V, LLC, General Partner, /s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, Authorized Signatory
Date:05/05/2026
Longitude 103.8 East Partners, LLC
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, Authorized Signatory
Date:05/05/2026
Longitude 103.8 East, L.P.
Signature:By Longitude 103.8 East Partners, LLC, General Partner, /s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, Authorized Signatory
Date:05/05/2026
Patrick G. Enright
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, as attorney-in-fact for Patrick G. Enright
Date:05/05/2026
Juliet Tammenoms Bakker
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, as attorney-in-fact for Juliet Tammenoms Bakker
Date:05/05/2026

Categories

SEC Filings